BioXcel Therapeutics reported a gross margin of 87.91% and a net margin of -7,867.58% for the quarter ended Jun 2026. These financial ratios cover 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||
| Gross Margin | 91.97% | 96.22% | 95.63% | 94.31% | -50.15% | -89.89% | 86.25% | 94.38% | -446.73% | -127.32% | 91.67% | 10.83% | 88.78% | 87.50% | -37.38% | 87.91% | |||||||||||||||||||
| EBT Margin | -30,559.85% | -22,826.89% | -25,509.71% | -11,827.57% | -14,803.81% | -5,947.87% | -4,608.76% | -1,841.03% | -8,629.44% | -3,868.03% | -8,222.02% | -16,536.67% | -18,739.80% | -5,608.20% | -6,898.06% | -7,867.58% | |||||||||||||||||||
| EBIT Margin | -28,459.85% | -22,224.37% | -24,853.40% | -11,469.15% | -14,163.34% | -5,285.90% | -4,151.72% | -1,566.67% | -7,146.26% | -2,866.94% | -6,011.31% | -13,210.00% | -14,518.37% | -4,016.41% | -4,962.62% | -5,600.55% | |||||||||||||||||||
| EBITDA Margin | -28,459.85% | -22,224.37% | -24,853.40% | -11,469.15% | -14,163.34% | -5,285.90% | -4,151.72% | -1,566.67% | -7,146.26% | -2,866.94% | -6,011.31% | -13,210.00% | -14,518.37% | -4,016.41% | -4,962.62% | -5,600.55% | |||||||||||||||||||
| Operating Margin | -28,459.85% | -22,224.37% | -24,853.40% | -11,469.15% | -14,163.34% | -5,285.90% | -4,151.72% | -1,566.67% | -7,146.26% | -2,866.94% | -6,011.31% | -13,210.00% | -14,518.37% | -4,016.41% | -4,962.62% | -5,600.55% | |||||||||||||||||||
| Net Margin | -30,559.85% | -22,826.89% | -25,509.71% | -11,827.57% | -14,803.81% | -5,947.87% | -4,608.76% | -1,841.03% | -8,629.44% | -3,868.03% | -8,222.02% | -16,536.67% | -18,739.80% | -5,608.20% | -6,898.06% | -7,867.58% | |||||||||||||||||||
| FCF Margin | -22,763.50% | -16,234.87% | -25,414.08% | -8,360.18% | -11,021.70% | -7,144.41% | -3,042.27% | -2,099.09% | -7,634.58% | -4,046.17% | -7,168.45% | -10,479.17% | -19,170.41% | -5,550.78% | -5,732.52% | -3,350.55% | |||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.04M | 1.40M | 1.70M | 1.97M | 1.94M | 1.97M | 2.00M | 2.21M | 2.56M | 2.10M | 1.10M | 0.66M | 0.57M | 0.48M | 0.59M | 0.61M | 0.49M | ||||||||||||||||||
| Assets AverageAssets Avg. | 271.22M | 250.39M | 225.24M | 229.64M | 246.53M | 225.34M | 192.98M | 160.10M | 120.27M | 87.08M | 78.01M | 73.88M | 57.16M | 43.62M | 38.45M | 32.18M | 35.29M | 44.85M | 39.47M | 31.41M | |||||||||||||||
| Invested CapitalInvested Cap. | 245.71M | 221.87M | 194.08M | 225.63M | 218.95M | 170.25M | 148.45M | 103.56M | 59.22M | 44.09M | 29.27M | 28.70M | 18.81M | 9.41M | 15.35M | 1.02M | 20.21M | 14.13M | -5.25M | -11.01M | |||||||||||||||
| Asset Utilization RatioAsset Util. | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -0.00M | -0.00M | -0.00M | -22.88 | -10.54 | -18.11 | -15.21 | -16.08 | -14.85 | -5.79 | -6.70 | -4.67 | -4.04 | -2.60 | -2.53 | -3.75 | -3.25 | -2.34 | -2.44 | -2.39 | |||||||||||||||
| Debt Ratio | 0.00 | 0.00 | 0.00 | 0.25 | 0.38 | 0.45 | 0.53 | 0.70 | 0.99 | 1.36 | 1.23 | 1.57 | 2.14 | 2.67 | 2.74 | 4.21 | 2.44 | 2.44 | 2.95 | 3.63 | |||||||||||||||
| Times Interest Earned | -0.00M | -0.00M | -0.00M | -22.88 | -10.54 | -18.11 | -15.21 | -16.08 | -14.85 | -5.79 | -6.70 | -4.67 | -4.04 | -2.60 | -2.53 | -3.75 | -3.25 | -2.34 | -2.44 | -2.39 | |||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -31.66 | -21.80 | -18.59 | -9.82 | -7.91 | -11.13 | -10.33 | -3.61 | -1.47 | -3.95 | -3.54 | -2.54 | -1.40 | -1.07 | -0.80 | -0.60 | -1.98 | -1.36 | -2.55 | -3.08 | |||||||||||||||
| Price to SalesP/S | 0.00M | 0.00M | 0.00M | 426.52 | 217.19 | 234.82 | 162.96 | 46.82 | 121.04 | 41.42 | 66.07 | 99.85 | 370.83 | 76.30 | 176.12 | 242.53 | |||||||||||||||||||
| Price to BookP/B | 3.46 | 2.57 | 3.02 | 2.25 | 2.61 | 7.87 | 10.24 | 33.24 | -1.82 | -1.56 | -1.31 | -0.70 | -0.30 | -0.16 | -0.12 | -0.11 | -0.41 | -0.20 | -0.34 | -0.38 | |||||||||||||||
| Enterprise Value | 596.28M | 335.87M | 384.63M | 136.39M | 98.92M | 410.87M | 377.48M | 67.37M | -15.90M | 23.07M | 20.70M | -4.58M | -14.49M | -14.69M | -19.91M | -6.59M | -0.98M | -9.22M | 19.10M | 30.34M | |||||||||||||||
| EV to EBIT | -22.24 | -12.85 | -12.22 | -3.76 | -2.54 | -7.77 | -7.37 | -1.29 | 0.33 | -1.16 | -0.86 | 0.26 | 0.95 | 1.40 | 1.97 | 0.42 | 0.07 | 0.90 | -1.87 | -2.98 | |||||||||||||||
| EV to EBITDA | -22.24 | -12.85 | -12.22 | -3.76 | -2.54 | -7.77 | -7.37 | -1.29 | 0.33 | -1.16 | -0.86 | 0.26 | 0.95 | 1.40 | 1.97 | 0.42 | 0.07 | 0.90 | -1.87 | -2.98 | |||||||||||||||
| Market Capitalization | 849.19M | 568.83M | 585.06M | 369.84M | 331.23M | 604.60M | 543.01M | 194.92M | 74.06M | 88.29M | 94.84M | 51.69M | 25.90M | 15.16M | 11.10M | 11.98M | 36.34M | 19.53M | 36.28M | 44.14M | |||||||||||||||
| Price to FCFP/FCF | -42.01 | -28.52 | -17.98 | -11.17 | -10.62 | -15.65 | -10.37 | -5.10 | -1.97 | -3.29 | -5.36 | -2.23 | -1.59 | -1.02 | -0.92 | -0.95 | -1.93 | -1.37 | -3.07 | -7.24 | |||||||||||||||
| EV to FCF | -29.50 | -16.84 | -11.82 | -4.12 | -3.17 | -10.63 | -7.21 | -1.76 | 0.42 | -0.86 | -1.17 | 0.20 | 0.89 | 0.99 | 1.65 | 0.52 | 0.05 | 0.65 | -1.62 | -4.98 | |||||||||||||||
| EV to CFO | -29.52 | -16.85 | -11.87 | -4.12 | -3.17 | -10.63 | -7.21 | -1.76 | 0.42 | -0.86 | -1.17 | 0.20 | 0.89 | 0.99 | 1.65 | 0.52 | 0.05 | 0.65 | -1.62 | -4.98 | |||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -28,459.85% | -22,224.37% | -24,853.40% | -11,469.15% | -14,163.34% | -5,285.90% | -4,151.72% | -1,566.67% | -7,146.26% | -2,866.94% | -6,011.31% | -13,210.00% | -14,518.37% | -4,016.41% | -4,962.62% | -5,600.55% | |||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -39.71% | -45.75% | -53.54% | -57.58% | -59.55% | -82.96% | -109.23% | -155.95% | -253.27% | -287.22% | -311.08% | -235.31% | -242.44% | -314.49% | -412.06% | 4,316.81% | 2,015.99% | 556.23% | 325.86% | 42.49% | |||||||||||||||
| Return on Assets [ROA]ROA | -37.57% | -42.70% | -49.73% | -53.15% | -55.61% | -73.37% | -96.60% | -126.67% | -175.78% | -206.08% | -197.05% | -162.42% | -153.91% | -182.90% | -173.62% | -205.99% | -187.53% | -147.99% | -169.18% | -194.99% |